These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14746591)

  • 21. Radiotherapy for thyroid orbitopathy. Effects on extraocular muscle balance.
    Wilson WB; Prochoda M
    Arch Ophthalmol; 1995 Nov; 113(11):1420-5. PubMed ID: 7487604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The manifestations of 496 cases with thyroid-related immune orbitopathy and normal thyroid function].
    Sun F; Song G; Tian W; Zhao H; Pan Y
    Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):283-6. PubMed ID: 11877209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy and Side Effects of Lateral Orbital Wall Decompression Including the Orbital Rim in Patients with Graves' Orbitopathy].
    Horn M; Schittkowski MP
    Klin Monbl Augenheilkd; 2019 Jan; 236(1):17-24. PubMed ID: 30690696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late recurrence of unilateral graves orbitopathy on the contralateral side.
    Kalmann R; Mourits MP
    Am J Ophthalmol; 2002 May; 133(5):727-9. PubMed ID: 11992884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extraocular muscle involvement in marginal zone B-cell lymphomas of the orbit.
    Izambart C; Robert PY; Petellat F; Petit B; Gastaud P; Lagier J; Labrousse F; Adenis JP
    Orbit; 2008; 27(5):345-9. PubMed ID: 18836931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How predictable is exophthalmos reduction in Graves' orbitopathy? A review of the literature.
    Borumandi F; Hammer B; Kamer L; von Arx G
    Br J Ophthalmol; 2011 Dec; 95(12):1625-30. PubMed ID: 21349939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The removal of the deep lateral wall in orbital decompression: its contribution to exophthalmos reduction and influence on consecutive diplopia.
    Baldeschi L; MacAndie K; Hintschich C; Wakelkamp IM; Prummel MF; Wiersinga WM
    Am J Ophthalmol; 2005 Oct; 140(4):642-7. PubMed ID: 16140250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Graves' orbitopathy and the thyrotropin-releasing hormone (TRH) test.
    Rush JA; Older JJ
    J Clin Neuroophthalmol; 1981 Sep; 1(3):219-24. PubMed ID: 6213665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orbital decompression for disfiguring exophthalmos in thyroid orbitopathy.
    Lyons CJ; Rootman J
    Ophthalmology; 1994 Feb; 101(2):223-30. PubMed ID: 8115142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid orbitopathy.
    Fung S; Malhotra R; Selva D
    Aust Fam Physician; 2003 Aug; 32(8):615-20. PubMed ID: 12973869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prominent proptosis in childhood thyroid eye disease.
    Liu GT; Heher KL; Katowitz JA; Kazim M; Moazami G; Moshang T; Teener JW; Sladky J; Volpe NJ; Galetta SL
    Ophthalmology; 1996 May; 103(5):779-84. PubMed ID: 8637687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy.
    Ben Simon GJ; Syed HM; Douglas R; McCann JD; Goldberg RA
    Am J Ophthalmol; 2004 Jun; 137(6):1145-7. PubMed ID: 15183812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience.
    Prummel MF; Bakker A; Wiersinga WM; Baldeschi L; Mourits MP; Kendall-Taylor P; Perros P; Neoh C; Dickinson AJ; Lazarus JH; Lane CM; Heufelder AE; Kahaly GJ; Pitz S; Orgiazzi J; Hullo A; Pinchera A; Marcocci C; Sartini MS; Rocchi R; Nardi M; Krassas GE; Halkias A
    Eur J Endocrinol; 2003 May; 148(5):491-5. PubMed ID: 12720530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiologically manifested accessory extraocular muscles in thyroid eye disease.
    Sinclair NE; Roberts MA; Hourihan MD; Walters RF; Lane CM
    Ophthalmic Plast Reconstr Surg; 2010; 26(4):286-8. PubMed ID: 20502362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Concentrations of soluble vascular cell adhesion molecule-1 (sVCAM-1) in patients witt Graves' disease and thyroid associated orbitopathy].
    Kulig G; Pilarska K; Kulig J
    Przegl Lek; 2004; 61(12):1319-24. PubMed ID: 15850321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound in early thyroid orbitopathy.
    Shammas HJ; Minckler DS; Ogden C
    Arch Ophthalmol; 1980 Feb; 98(2):277-9. PubMed ID: 6892557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
    Juri J; Stiglmayer N; Kuzman T
    Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired diplopia. Not always a neurologic problem.
    Keltner JL; Burde RM; Miller NR; Gittinger JW
    Surv Ophthalmol; 1982; 26(6):345-9. PubMed ID: 6896771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rectus extraocular muscle paths and decompression surgery for Graves orbitopathy: mechanism of motility disturbances.
    Abràmoff MD; Kalmann R; de Graaf ME; Stilma JS; Mourits MP
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):300-7. PubMed ID: 11818370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in proptosis following extraocular muscle surgery: effects of muscle recession in thyroid-associated orbitopathy.
    Gomi CF; Yang SW; Granet DB; Kikkawa DO; Langham KA; Banuelos LR; Levi L
    J AAPOS; 2007 Aug; 11(4):377-80. PubMed ID: 17409001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.